Rocket Pharmaceuticals (RCKT) Short Interest Ratio & Short Volume $8.79 -0.66 (-6.98%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$8.74 -0.05 (-0.63%) As of 08:24 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Rocket Pharmaceuticals Short Interest DataRocket Pharmaceuticals (RCKT) has a short interest of 11.24 million shares, representing 17.25% of the float (the number of shares available for trading by the public). This marks a 6.84% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.8, indicating that it would take 7.8 days of the average trading volume of 1.44 million shares to cover all short positions.Current Short Interest11,240,000 sharesPrevious Short Interest10,520,000 sharesChange Vs. Previous Month+6.84%Dollar Volume Sold Short$117.68 millionShort Interest Ratio7.8 Days to CoverLast Record DateFebruary 15, 2025Outstanding Shares91,157,000 sharesShort Percent of Float17.25%Today's Trading Volume1,489,256 sharesAverage Trading Volume1,440,665 sharesToday's Volume Vs. Average103% Short Selling Rocket Pharmaceuticals? Sign up to receive the latest short interest report for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRCKT Short Interest Over TimeRCKT Days to Cover Over TimeRCKT Percentage of Float Shorted Over Time Rocket Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/15/202511,240,000 shares $117.68 million +6.8%17.2%7.8 $10.47 1/31/202510,520,000 shares $112.98 million -10.1%N/A7.4 $10.74 1/15/202511,700,000 shares $127.30 million -9.5%N/A9 $10.88 12/31/202412,930,000 shares $162.53 million +15.7%N/A11.3 $12.57 12/15/202411,180,000 shares $134.38 million +7.6%N/A10.4 $12.02 11/30/202410,390,000 shares $149.51 million -6.3%N/A11.2 $14.39 11/15/202411,090,000 shares $155.04 million -6.8%N/A12.1 $13.98 10/31/202411,900,000 shares $198.14 million +3.3%N/A14.3 $16.65 10/15/202411,520,000 shares $192.15 million +1.1%N/A13.5 $16.68 9/30/202411,400,000 shares $210.56 million +1.2%N/A13.1 $18.47 Get the Latest News and Ratings for RCKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/15/202411,260,000 shares $221.26 million +3.0%N/A13 $19.65 8/31/202410,930,000 shares $206.03 million +0.1%N/A13.1 $18.85 8/15/202410,920,000 shares $203.11 million +3.7%N/A13 $18.60 7/31/202410,530,000 shares $254.83 million +9.2%N/A13 $24.20 7/15/20249,640,000 shares $217.38 million +14.6%N/A12.1 $22.55 6/30/20248,410,000 shares $181.07 million -9.2%N/A10.7 $21.53 6/15/20249,260,000 shares $202.42 million -1.6%N/A13.1 $21.86 5/31/20249,410,000 shares $200.62 million -5.8%N/A14.2 $21.32 5/15/20249,990,000 shares $236.36 million +1.5%N/A14.6 $23.66 4/30/20249,840,000 shares $211.76 million -10.6%N/A13.5 $21.52 4/15/202411,000,000 shares $264.11 million +4.6%N/A15.3 $24.01 3/31/202410,520,000 shares $283.41 million +2.7%N/A14.7 $26.94 3/15/202410,240,000 shares $274.53 million +2.8%N/A13.6 $26.81 2/29/20249,960,000 shares $291.83 million +8.3%N/A12 $29.30 2/15/20249,200,000 shares $280.78 million +8.9%N/A11.3 $30.52 1/31/20248,450,000 shares $242.77 million +2.4%N/A10.4 $28.73 1/15/20248,250,000 shares $236.03 million -4.2%N/A9.3 $28.61 12/31/20238,610,000 shares $258.04 million -6.5%N/A9.7 $29.97 12/15/20239,210,000 shares $260.74 million +0.9%N/A10 $28.31 11/30/20239,130,000 shares $213.00 million +0.4%N/A6.7 $23.33 11/15/20239,090,000 shares $198.53 million +0.4%N/A7 $21.84 10/31/20239,050,000 shares $163.81 million +0.7%N/A7.2 $18.10 10/15/20238,990,000 shares $157.77 million -6.5%N/A7.6 $17.55 9/30/20239,610,000 shares $196.91 million +6.7%N/A8.3 $20.49 9/15/20239,010,000 shares $211.28 million +24.5%N/A8.2 $23.45 8/31/20237,240,000 shares $113.31 million -6.2%N/A12 $15.65 8/15/20237,720,000 shares $125.37 million -1.0%N/A11.9 $16.24 7/31/20237,800,000 shares $140.79 million -2.1%N/A11.6 $18.05 7/15/20237,970,000 shares $157.17 million -2.9%N/A11.6 $19.72 6/30/20238,210,000 shares $163.13 million -1.9%N/A11.8 $19.87URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now 6/15/20238,370,000 shares $190.42 million +6.0%N/A10.9 $22.75 5/31/20237,900,000 shares $165.35 million -2.5%N/A9.7 $20.93 5/15/20238,100,000 shares $176.34 million +0.9%N/A9.8 $21.77 4/30/20238,030,000 shares $143.90 million -2.3%N/A9.6 $17.92 4/15/20238,220,000 shares $146.64 million -9.3%N/A9.7 $17.84 3/31/20239,060,000 shares $155.20 million +1.5%N/A10.5 $17.13 3/15/20238,930,000 shares $160.83 million +7.5%N/A9.5 $18.01 2/28/20238,310,000 shares $159.64 million +9.9%N/A9.2 $19.21 2/15/20237,560,000 shares $148.33 million +11.0%N/A8.6 $19.62 1/31/20236,810,000 shares $147.98 million -8.1%N/A7.5 $21.73 1/15/20237,410,000 shares $165.76 million +5.3%N/A8.1 $22.37 12/30/20227,040,000 shares $137.77 million +0.1%N/A7.7 $19.57 12/15/20227,030,000 shares $154.80 million -7.9%N/A6.8 $22.02 11/30/20227,630,000 shares $144.05 million -2.3%N/A7.6 $18.88 11/15/20227,810,000 shares $161.67 million -16.9%N/A7.8 $20.70 10/31/20229,400,000 shares $175.40 million -0.5%N/A9.7 $18.66 10/15/20229,450,000 shares $154.41 million -16.4%15.5%9.7 $16.34 9/30/202211,300,000 shares $180.35 million -3.9%18.5%11.7 $15.96 9/15/202211,760,000 shares $183.22 million +8.3%19.2%13.5 $15.58 8/31/202210,860,000 shares $167.35 million +1.1%17.8%14.2 $15.41 8/15/202210,740,000 shares $196.76 million +18.9%17.6%13.1 $18.32 7/31/20229,030,000 shares $130.94 million +5.2%14.8%9.8 $14.50 7/15/20228,580,000 shares $138.31 million +4.0%14.1%9.7 $16.12 6/30/20228,250,000 shares $113.52 million +4.2%13.6%9.7 $13.76 6/15/20227,920,000 shares $86.96 million -4.6%13.0%10.2 $10.98 5/31/20228,300,000 shares $98.36 million +10.1%13.7%12 $11.85 5/15/20227,540,000 shares $68.54 million -0.3%12.4%12.9 $9.09 4/30/20227,560,000 shares $77.72 million -12.6%12.6%15.2 $10.28 4/15/20228,650,000 shares $117.29 million -1.3%14.5%18.3 $13.56 3/31/20228,760,000 shares $138.93 million +3.8%14.7%19.2 $15.86 3/15/20228,440,000 shares $116.30 million +2.1%14.1%15.7 $13.78 2/28/20228,270,000 shares $147.29 million +1.2%14.0%15.2 $17.81 2/15/20228,170,000 shares $163.40 million +4.6%13.8%15.2 $20.00 1/31/20227,810,000 shares $129.96 million -9.2%13.8%14.5 $16.64 1/15/20228,600,000 shares $161.42 million +9.3%14.1%17 $18.77 12/31/20217,870,000 shares $171.80 million -2.6%12.9%16.9 $21.83 12/15/20218,080,000 shares $186.73 million +4.5%13.2%20.6 $23.11 11/30/20217,730,000 shares $188.84 million +0.7%12.6%22.2 $24.43 11/15/20217,680,000 shares $198.91 million -2.5%12.5%20.8 $25.90 10/29/20217,880,000 shares $234.11 million +0.9%12.8%20 $29.71 10/15/20217,810,000 shares $218.06 million -3.6%12.7%18.4 $27.92 9/30/20218,100,000 shares $242.11 million +2.4%13.1%17.6 $29.89 9/15/20217,910,000 shares $269.34 million +0.1%12.8%16.9 $34.05 8/31/20217,900,000 shares $270.26 million +2.3%12.8%17.2 $34.21 8/13/20217,720,000 shares $230.98 million -3.7%12.7%18.7 $29.92 7/30/20218,020,000 shares $287.28 million +5.3%13.2%20.4 $35.82 7/15/20217,620,000 shares $326.90 million -0.4%12.6%21.2 $42.90 6/30/20217,650,000 shares $338.82 million -4.0%12.6%21.8 $44.29 6/15/20217,970,000 shares $370.61 million -1.1%13.1%20.1 $46.50 5/28/20218,060,000 shares $342.55 million -1.0%13.3%18.6 $42.50URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now 5/14/20218,140,000 shares $333.25 million +2.3%N/A17.3 $40.94 4/30/20217,960,000 shares $368.15 million -3.2%N/A16 $46.25 4/15/20218,220,000 shares $357.82 million -6.7%N/A16.7 $43.53 3/31/20218,810,000 shares $381.83 million +7.2%N/A17.3 $43.34 3/15/20218,220,000 shares $440.76 million -0.4%N/A15.7 $53.62 2/26/20218,250,000 shares $427.85 million +0.7%N/A11.2 $51.86 2/12/20218,190,000 shares $489.11 million -1.3%N/A11.2 $59.72 1/29/20218,300,000 shares $453.01 million +0.7%N/A11.5 $54.58 1/15/20218,240,000 shares $480.97 million +0.1%N/A11.9 $58.37 12/31/20208,230,000 shares $461.29 million -10.8%N/A12.3 $56.05 12/15/20209,230,000 shares $517.53 million +1.5%N/A14.8 $56.07 11/30/20209,090,000 shares $291.24 million -0.6%N/A19.9 $32.04 11/15/20209,140,000 shares $292.21 million -5.8%N/A30.3 $31.97 10/30/20209,700,000 shares $279.65 million +0.6%N/A35.5 $28.83 10/15/20209,640,000 shares $268.76 million +0.8%N/A34.6 $27.88 9/30/20209,560,000 shares $218.54 million +0.5%N/A32 $22.86 9/15/20209,510,000 shares $230.81 million +0.4%N/A25.9 $24.27 8/31/20209,470,000 shares $242.15 million -0.3%N/A23.1 $25.57 8/14/20209,500,000 shares $261.16 million +2.6%N/A22.1 $27.49 7/31/20209,260,000 shares $217.89 million +0.3%N/A21.1 $23.53 7/15/20209,230,000 shares $215.06 million +4.5%N/A20.6 $23.30 6/30/20208,830,000 shares $186.22 million +6.5%N/A19.8 $21.09 6/15/20208,290,000 shares $161.49 million -1.1%N/A20.8 $19.48 5/29/20208,380,000 shares $157.63 million +2.7%N/A20.4 $18.81 5/15/20208,160,000 shares $161.89 million +0.5%N/A18.7 $19.84 4/30/20208,120,000 shares $120.18 million -1.8%N/A18.5 $14.80 4/15/20208,270,000 shares $128.43 million +7.1%N/A19.6 $15.53 3/31/20207,720,000 shares $134.02 million +2.1%N/A18.3 $17.36 3/13/20207,560,300 shares $120.06 million +6.5%N/A14.1 $15.88 RCKT Short Interest - Frequently Asked Questions What is Rocket Pharmaceuticals' current short interest? Short interest is the volume of Rocket Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of February 15th, traders have sold 11,240,000 shares of RCKT short. 17.25% of Rocket Pharmaceuticals' shares are currently sold short. Learn More on Rocket Pharmaceuticals' current short interest. What is a good short interest ratio for Rocket Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RCKT shares currently have a short interest ratio of 8.0. Learn More on Rocket Pharmaceuticals's short interest ratio. Which institutional investors are shorting Rocket Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Rocket Pharmaceuticals: Wolverine Trading LLC, Group One Trading LLC, Caption Management LLC, Citadel Advisors LLC, and Barclays PLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Rocket Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.25% of Rocket Pharmaceuticals' floating shares are currently sold short. Is Rocket Pharmaceuticals' short interest increasing or decreasing? Rocket Pharmaceuticals saw a increase in short interest in February. As of February 15th, there was short interest totaling 11,240,000 shares, an increase of 6.8% from the previous total of 10,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Rocket Pharmaceuticals' short interest compare to its competitors? 17.25% of Rocket Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Rocket Pharmaceuticals: Avidity Biosciences, Inc. (14.34%), Zai Lab Limited (8.04%), Biohaven Ltd. (10.15%), Alvotech (0.39%), Scholar Rock Holding Co. (21.13%), Immunovant, Inc. (21.33%), Recursion Pharmaceuticals, Inc. (25.40%), Akero Therapeutics, Inc. (7.45%), Arcellx, Inc. (17.78%), Apellis Pharmaceuticals, Inc. (14.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks. What does it mean to sell short Rocket Pharmaceuticals stock? Short selling RCKT is an investing strategy that aims to generate trading profit from Rocket Pharmaceuticals as its price is falling. RCKT shares are trading down $0.66 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rocket Pharmaceuticals? A short squeeze for Rocket Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RCKT, which in turn drives the price of the stock up even further. How often is Rocket Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RCKT, twice per month. The most recent reporting period available is February, 15 2025. More Short Interest Resources from MarketBeat Related Companies Avidity Biosciences Short Squeeze Zai Lab Short Squeeze Biohaven Short Squeeze Alvotech Short Squeeze Scholar Rock Short Squeeze Immunovant Short Squeeze Recursion Pharmaceuticals Short Squeeze Akero Therapeutics Short Squeeze Arcellx Short Squeeze Apellis Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RCKT) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredWhy 2026 will be a disaster for many AmericansWall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
